๐ฐ Bertram Pitt News
Page 2 - Bertram Pitt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bertram Pitt. Real-time updates on events, politics, business and more.
December 30, 2022
Operator: Good day, ladies and gentlemen. Welcome to the Lexicon Pharmaceuticals Inc. Third Quarter 2022 Earnings Conference Call. At this time all lines are in a listen-only mode.
November 10, 2022
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30- and 90-Days Following Hospital Dischargeย
November 10, 2022
Lexicon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:LXRX) Q3 2022 Earnings Conference Call November 09, 2022 5:00 PM ET Company Participants Mike Kelly โ Investor Relations Lonnel Coats โ Chief...
November 7, 2022
The results of the TRANSFORM-HF study, which explored the effects of two different therapies on heart failure outcomes, were featured during the first
November 6, 2022
In a head-to-head comparison of two so-called 'water pills' that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.
November 6, 2022
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30 and 90 Days Following...
October 28, 2022
Patients with CKD and type 2 diabetes, who have higher risks of pneumonia and severe COVID-19, might benefit from finerenone.
October 26, 2022
Secondary analyses from 13,026 people with type 2 diabetes and CKD in the finerenone pivotal trials showed that the agent was linked with less infective pneumonia and blunted COVID-19 severity.
October 4, 2022
New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failureย
October 2, 2022
Data presented at the Heart Failure Society of America annual scientific meetingNew analysis adds to growing body of evidence in support of the use of...